Cargando…
Propofol suppresses cell proliferation in gastric cancer cells through NRF2‐mediated polyol pathway
Propofol, a widely used short‐acting intravenous sedative agent, has gradually gained attention due to the tumour‐suppressing role and non‐anaesthetic effect. Dysfunction of metabolic reprogramming has been recognised as a well‐documented factor for tumour progression. The aim of this study is to ex...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299175/ https://www.ncbi.nlm.nih.gov/pubmed/34570396 http://dx.doi.org/10.1111/1440-1681.13595 |